Page 308 - medicina-integrativa_compress

304 PARTE II, SECCIÓN 4 ENFERMEDADES CARDIOVASCULARES

21. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, 46. Halpin LS, Speir AM, CapoBianco P, Barnett SD: Guided imagery
omega-3 fatty acids, and cardiovascular disease. Circulation 106: in cardiac surgery. Outcomes Manage 6:132-137, 2002.
2747-2757, 2003. 47. Peng CK, Mietus JE, Liu Y, et al: Exaggerated heart rate oscillations
22. Ascherio A, Katan MB, Zock PL, et al: Trans fatty acids and coronary during two meditation techniques. Int J Cardiol 70:101-107, 1999.
heart disease. N Engl J Med 340:1994-1998, 1999. 48. Schneider RH, Alexander CN, Staggers F, et al: Long-term effects of
23. Anderson JW, Smith BM, Washnock CS: Cardiovascular and renal stress reduction on mortality in persons ≥ 55 years of age with
benefits of dry bean and soybean intake. Am J Clin Nutr 70(3 Suppl): systemic hypertension. Am J Cardiol 95:1060-1064, 2005.
464S-474S, 1999. 49. Blumenthal JA, Babyak M, Wei J, et al: Usefulness of psychosocial
24. Brand-Miller JC: Glycemic load and chronic disease. Nutr Rev treatment of mental stress-induced myocardial ischemia in men.
61:S49-S55, 2003. Am J Cardiol 89:164-168, 2002.
25. Hu FB: The Mediterranean diet and mortality—olive oil and beyond. 50. Miller KL, Liebowitz RS, Newby LK: Complementary and alternative
N Engl J Med 348:2595-2596, 2003. medicine in cardiovascular disease: A review of biologically based
26. de Lorgeril M, Salen P, Martin JL, et al: Mediterranean diet, approaches. Am Heart J 147:401-411, 2004.
traditional risk factors, and the rate of cardiovascular complications 51. Valli G, Giardina EG: Benefits, adverse effects, and drug interactions
after myocardial infarction: Final report of the Lyon Diet Heart of herbal therapies with cardiovascular effects. J Am Coll Cardiol
Study. Circulation 99:779-785, 1999. 39:1083-1095, 2002.
27. Esposito K, Marfella R, Ciotola M, et al: Effect of a Mediterranean-style 52. Morris CD, Carson S: Routine vitamin supplementation to prevent
diet on endothelial dysfunction and markers of vascular cardiovascular disease: A summary of the evidence for the U.S.
inflammation in the metabolic syndrome: A randomized trial. JAMA Preventive Services Task Force. Ann Intern Med 139:56-70, 2003.
292:1440-1446, 2004. 53. Salonen JT: Clinical trials testing cardiovascular benefits of
28. Franco OH, Bonneux L, de Laet C, et al: The Polymeal: A more natural, antioxidant supplementation. Free Radic Res 36:1299-1306, 2002.
safer, and probably tastier (than the Polypill) strategy to reduce 54. Miller ER, Pastor-Barrtuso R, Dalal D, et al: Meta-analysis: High-
cardiovascular disease by more than 75%. BMJ 329:1447-1450, 2004. dosage vitamin E supplementation may increase all-cause mortality.
29. Jenkins DJ, Kendall CW, Marchie A, et al: Direct comparison of a Ann Intern Med 142:37-46, 2005.
dietary portfolio of cholesterol-lowering foods with a statin in 55. Stampfer MJ, Jakubowski JA, Faigel D, et al: Vitamin E
hypercholesterolemic participants. Am J Clin Nutr 81:380-387, 2005. supplementation effect on human platelet function, arachidonic
30. Geleijnse JM, Launer LJ, Van der Kuip DA, et al: Inverse association acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr
of tea and flavonoid intakes with incident myocardial infarction: The 47:700-706, 1988.
Rotterdam Study. Am J Clin Nutr 75:880-886, 2002. 56. Packer L, Witt EH, Tritschler HJ: Alpha-Lipoic acid as a biological
31. Son DJ, Cho MR, Jin YR, et al: Antiplatelet effect of green tea antioxidant. Free Radic Biol Med 19:227-250, 1995.
catechins: A possible mechanism through arachidonic acid pathway. 57. Lerman A, Burnett JC Jr, Higano ST, et al: Long-term L-arginine
Prostaglandins Leukot Essent Fatty Acids 71:25-31, 2004. supplementation improves small-vessel coronary endothelial function
32. Law MR: Plant sterol and stanol margarines and health. West J Med in humans. Circulation 97:2123-2128, 1998.
173:43-47, 2000. 58. Blum A, Porat R, Rosenschein U, et al: Clinical and inflammatory
33. Lissin LW, Cooke JP: Phytoestrogens and cardiovascular health. effects of dietary L-arginine in patients with intractable angina
J Am Coll Cardiol 35:1403-1410, 2000. pectoris. Am J Cardiol 83:1488-1490, A8, 1999.
34. Hu FB, Stampfer MJ, Manson JE, et al: Frequent nut consumption 59. Blum A, Hathaway L, Mincemoyer R, et al: Oral L-arginine in
and risk of coronary heart disease in women: Prospective cohort patients with coronary artery disease on medical management.
study. BMJ 317:1341-1345, 1998. Circulation 101:2160-2164, 2000.
35. Goldberg IJ, Mosca L, Piano MR, Fisher EA: AHA Science Advisory: 60. AHFS: AHFS Drug Information. Bethesda, MD, American Society
Wine and your heart: A science advisory for healthcare professionals of Health-System Pharmacists, 1997.
from the Nutrition Committee, Council on Epidemiology and 61. Schulman SP, Becker LC, Kass DA, et al: L-arginine therapy in acute
Prevention, and Council on Cardiovascular Nursing of the American myocardial infarction. The vascular interaction with age in myocardial
Heart Association. Circulation 103:472-475, 2001. infarction (VINTAGE MI) randomized clinical trial. JAMA 295:
36. AHA: American Heart Association guidelines for weight management 58-64, 2006.
programs for healthy adults. AHA Nutrition Committee. Heart Dis 62. Goral S: Levocarnitine and muscle metabolism in patients with
Stroke 3:221-228, 1994. end-stage renal disease. J Ren Nutr 8:118-121, 1998.
37. Gill JM, Al-Mamari A, Ferrell WR, et al: Effects of prior 63. Anand I, Chandrashekan Y, De Giuli F, et al: Acute and chronic
moderate exercise on postprandial metabolism and vascular effects of propionyl-L-carnitine on the hemodynamics, exercise
function in lean and centrally obese men. J Am Coll Cardiol 44: capacity, and hormones in patients with congestive heart failure.
2375-2382, 2004. Cardiovasc Drugs Ther 12:291-299, 1998.
38. Kraus WE, Houmard JA, Duscha BD, et al: Effects of the amount and 64. Martinez E, Domingo P, Roca-Cusachs A: Potentiation of
intensity of exercise on plasma lipoproteins. N Engl J Med 347: acenocoumarol action by L-carnitine. J Intern Med 233:94, 1993.
1483-1492, 2002. 65. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl
39. Lee IM, Rexrode KM, Cook NR, et al: Physical activity and coronary J Med 338:1042-1050, 1998.
heart disease in women: Is "no pain, no gain" passe? JAMA 285: 66. Wald DS, Bishop L, Wald NJ, et al: Randomized trial of folic acid
1447-1454, 2001. supplementation and serum homocysteine levels. Arch Intern Med
40. Hu FB, Li TY, Colditz GA, et al: Television watching and other 161:695-700, 2001.
sedentary behaviors in relation to risk of obesity and type 2 diabetes 67. Jones K, Hughes K, Mischley L, McKenna DJ: Coenzyme Q 10 and
mellitus in women. JAMA 289:1785-1791, 2003. cardiovascular health. Altern Ther Health Med 10:22-30; quiz 1, 2004.
41. van Dixhoorn JJ, Duivenvoorden HJ: Effect of relaxation therapy on 68. Chen YF, Lin YT, Wu SC: Effectiveness of coenzyme Q 10 on
cardiac events after myocardial infarction: A 5-year follow-up study. myocardial preservation during hypothermic cardioplegic arrest.
J Cardiopulm Rehabil 19:178-185, 1999. J Thorac Cardiovasc Surg 107:242-247, 1994.
42. Luskin F: Review of the effect of spiritual and religious factors on 69. Burke BE, Neuenschwander R, Olson RD: Randomized, double-
mortality and morbidity with a focus on cardiovascular and blind, placebo-controlled trial of coenzyme Q 10 in isolated systolic
pulmonary disease. J Cardiopulm Rehabil 20:8-15, 2000. hypertension. South Med J 94:1112-1117, 2001.
43. Rozanski A, Blumenthal JA, Davidson KW, et al: The epidemiology, 70. Heck AM, DeWitt BA, Lukes AL: Potential interactions between
pathophysiology, and management of psychosocial risk factors in alternative therapies and warfarin. Am J Health Syst Pharm 57:
cardiac practice: The emerging field of behavioral cardiology. J Am 1221-1227; quiz 8-30, 2000.
Coll Cardiol 45:637-651, 2005. 71. Din JN, Newby DE, Flapan AD: Omega 3 fatty acids and
44. Ford DE, Erlinger TP: Depression and C-reactive protein in US cardiovascular disease—fishing for a natural treatment. BMJ 328:
adults: Data from the Third National Health and Nutrition 30-35, 2004.
Examination Survey. Arch Intern Med 164:1010-1014, 2004. 72. Vanschoonbeek K, Feijge MA, Paquay M, et al: Variable
45. Rossi EL: Psychosocial genomics: Gene expression, neurogenesis, and hypocoagulant effect of fish oil intake in humans: Modulation of
human experience in mind-body medicine. Adv Mind Body Med fibrinogen level and thrombin generation. Arterioscler Thromb Vasc
18:22-30, 2002. Biol 24:1734-1740, 2004.